Assessment of estimated GFR and clinical predictors of contrast induced nephropathy among diabetic patients undergoing cardiac catheterization

Egyptian Heart Journal

Volumn 67, Issue 3, 2014, Pages 249-258

  Zaki, Tarek ^a   Samir, Ayman ^a   Mohammed Rashid, Tarek ^a   Galal, Haitham ^a   Samir, Wesam ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

CIN; Contrast media; Diabetes

Indexed keywords

CREATININE; IOVERSOL;

ADULT; AGED; ANAMNESIS; ANEMIA; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL EXAMINATION; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETIC PATIENT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART CATHETERIZATION; HEART DISEASE; HEART EJECTION FRACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; RISK ASSESSMENT; SMOKING;

EID: 84955175567     PISSN: 11102608     EISSN: 2090911X     Source Type: Journal    
DOI: 10.1016/j.ehj.2014.07.001     Document Type: Article

References (22)

1. Cavusoglu E., Chhabra S., et al. The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Minerva Cardioangiol 2004, 52(5):419-432.
2. Mehran R., Aymong E.D., Nikolsky E., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004, 44:1393-1399.
3. Harjai K.J., et al. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system. Am J Cardiol 2008, 101(6):812-819.
4. Smith H.W. Comparative physiology of the kidney. The kidney: structure and function in health and disease 1951, 5250-5274. Oxford University Press, New York. H.W. Smith (Ed.).
5. Froissart M., Rossert J., Jacquot C., et al. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 2005, 16(3):763-773.
6. Levey A.S., Coresh J., Balk E., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification and stratification. Ann Intern Med 2003, 139:137-147.
7. Cockcroft D.W., Gault H.M. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
8. American Diabetes Association Standards of medical care for patients with diabetes mellitus. Diabetes Care 2001, 24:S33-S43.
9. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation: Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
10. Hallan S., Asberg A., Lindberg M., Johnsen H. Validation of the modification of diet in renal disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. Am J Kidney Dis 2004, 44:84-93.
11. Levey A.S., Perrone R.D., Madias N.E. Serum creatinine and renal function. Annu Rev Med 1988, 39:465-490.
12. Barrett B.J., Parfrey P.S. Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med 1994, 331:1449-1450.
13. Goldenberg I., Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ 2005, 172:1461-1471.
14. Xue-chao Wang, Xiang-hua FU, Yan-bo WANG, et al. Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate. China Med J 2011, 124(6):892-896.
15. EL Etriby A., Taher A., El Kilany W. Frequency and predictors of contrast-induced nephropathy after cardiac catheterization in type ii diabetic patients. Heart Mirror J 2012, 6(1):22-26.
16. Eric C., Kian K., Shen L., Huay C.T. Risk factors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine. J Nephrol 2010, 25(5):776-781.
17. Yong L., Tan N., Zhou Y.L., et al. The contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy after primary percutaneous coronary intervention. Int Urol Nephrol 2012, 44(1):221-229.
18. Mehran R., Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl 2006, 100:S11-S15.
19. Tan N., Liu Y., Zhou Y.L., et al. Contrast medium volume to creatinine clearance ratio: a predictor of contrast-induced nephropathy in the first 72h following percutaneous coronary intervention. Catheter Cardiovasc Interv 2012, 79(1):70-75.
20. Mujtaba S.H., Ashraf T., Nasir S., et al. Assessment of renal insufficiency in patients with normal serum creatinine levels undergoing angiography. J Pak Med Assoc 2010, 60(11):915-917.
21. Bariş N., Ozpelit E., Doğan N.B., et al. The effects of chronic usage of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers oncontrast-inducednephropathyin low-risk patients. Anadolu Kardiyol Derg 2012.
22. Umruddin Z., Moe K., Superdock K. ACE inhibitor or angiotensin II receptor blocker use is a risk factor for contrast-induced nephropathy. J Nephrol 2012, 25(5):776-781.